Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 102.00
+1.72 (1.72%)
Jul 23, 2025, 2:45 PM CST
SHA:688016 Revenue
Shanghai MicroPort Endovascular MedTech had revenue of 332.19M CNY in the quarter ending March 31, 2025, a decrease of -7.23%. This brings the company's revenue in the last twelve months to 1.18B, down -6.29% year-over-year. In the year 2024, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.21B with 1.61% growth.
Revenue (ttm)
1.18B
Revenue Growth
-6.29%
P/S Ratio
10.48
Revenue / Employee
1.43M
Employees
826
Market Cap
12.37B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |